-
(2E,6E,10E)-2,6,9,9-Tetramethylcycloundeca-2,6,10-trienone
-
BD272624471-05-695%
-
¥3737.0100mg
-
2-((5-Bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl)thio)acetic acid
-
BD435045878672-00-598%
-
¥217.0250mg
-
Sodium 2-((5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl)thio)acetate
-
BD3329541151516-14-198%
-
¥238.0250mg
-
2-((3-(4-Cyanonaphthalen-1-yl)pyridin-4-yl)thio)-2-methylpropanoic acid
-
BD6301691352792-74-598+%
-
¥845.050mg
-
N-((4-Bromophenyl)sulfonyl)-2-((3-(4-cyclopropylnaphthalen-1-yl)-4-oxo-3,4-dihydrothieno[2,3-d]pyrimidin-2-yl)thio)acetamide
-
BD016995822700292-02-898%
-
¥
-
URAT1 inhibitor 5
-
BD021710272102670-94-898%
-
¥
-
URAT1 inhibitor 3
-
BD023353522850331-30-398%
-
¥
-
KPH2f
-
BD015026482760615-09-498%
-
¥
-
1-((6-Bromoquinolin-4-yl)thio)cyclobutane-1-carboxylic acid
-
BD012216161638327-48-698%
-
¥33228.0100mg
-
URAT1 inhibitor 8
-
BD021676211632005-33-498%
-
¥
-
Puliginurad
-
BD015983322013582-27-798%
-
¥
-
URAT1 inhibitor 6
-
BD021911052244807-49-498%
-
¥
-
1-((5-Bromo-4-((4-bromonaphthalen-1-yl)methyl)-4H-1,2,4-triazol-3-yl)thio)-N-(pyridin-3-yl)methanesulfonamide
-
BD011397982268720-62-199+%
-
¥70148.0100mg
-
Xininurad
-
BD015666682365178-28-398%
-
¥
-
Lingdolinurad
-
BD023046342088176-96-798%
-
¥
-
URAT1 inhibitor 7
-
BD021828651632002-28-898%
-
¥
-
(3,5-Dibromo-4-hydroxyphenyl)(2,3-dihydro-4H-pyrido[4,3-b][1,4]oxazin-4-yl)methanone
-
BD012743521198153-15-998%
-
¥
-
URAT1 inhibitor 2
-
BD015088082803951-18-898%
-
¥